VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Stock Comparison
Alcon Inc. vs Pfizer Inc.
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Alcon Inc.
ALC · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Pfizer Inc.
PFE · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Comparison highlights
- Moat score gap: Alcon Inc. leads (71 / 100 vs 58 / 100 for Pfizer Inc.).
- Segment focus: Alcon Inc. has 2 segments (56% in Surgical); Pfizer Inc. has 5 segments (47.4% in Primary Care).
- Moat breadth: Alcon Inc. has 7 moat types across 3 domains; Pfizer Inc. has 8 across 3.
Primary market context
Alcon Inc.
Surgical
Ophthalmic surgical devices (implantables, consumables, equipment) and related service/training
Global
Ophthalmic surgeons, hospitals, ambulatory surgery centers, group purchasing organizations
Medical device OEM with direct service, clinical support, and training
56%
Pfizer Inc.
Primary Care
Branded primary care medicines and vaccines (incl. cardiovascular, migraine, pneumococcal/RSV/COVID-19)
Global
Healthcare providers, payers/PBMs, pharmacies/wholesalers, and government procurement
Innovator biopharma (R&D + manufacturing + commercialization)
47.4%
Side-by-side metrics
Moat coverage
Shared moat types
Alcon Inc. strengths
Pfizer Inc. strengths
Segment mix
Alcon Inc. segments
Full profile >Surgical
Oligopoly
Vision Care
Oligopoly
Pfizer Inc. segments
Full profile >Primary Care
Oligopoly
Specialty Care
Oligopoly
Oncology
Competitive
Pfizer CentreOne
Competitive
Pfizer Ignite
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listLooking for expansion-stage stocks?
Proven models entering the expansion stage with unit economics that work.
View expansion-stage stocksCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.